Amarin

Amarin to Present at the 11th Annual BIO CEO & Investor Conference

Published in Drug Law Weekly, February 17th, 2009

Amarin Corporation plc (NASDAQ: AMRN) announced that Mr. Thomas Lynch, Chairman and Chief Executive Officer, will present at the upcoming 11th Annual BIO CEO & Investor Conference on Monday, February 9, 2009 at 2.45 pm Eastern Time. The event will be held on February 9-10, 2009 at the Waldorf-Astoria Hotel in New York City.

The presentation will be webcast live and may be accessed by visiting the Investor Relations section of Amarin's website at www.amarincorp.com. An archived replay of the presentation will be available after the live presentation and can also be accessed at www.amarincorp.com. About Amarin Amarin is a clinical-stage biopharmaceutical company with a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2009-02-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry